Teva announced the launch of Carbamazepine ER Capsules, the generic version of Shire‘s Carbatrol Extended-Release Capsules. Carbatrol is indicated for the treatment of generalized tonic-clonic, partial, or mixed seizures, as well as the treatment of trigeminal or glossopharyngeal neuralgia.

Carbamazepine, a dibenzazepine, appears to act by reducing polysynaptic responses and blocking the post-tetanic potentiation. It greatly reduces or abolishes pain induced by stimulation of the infraorbital nerve, and depresses thalamic potential and bulbar and polysnaptic reflexes.

Carbamazepine ER Capsules are available in 100mg, 200mg, and 300mg dosage strengths in 120-count bottles.

For more information call (888) 838-2872 or visit